Acasti Pharma

+$0.0668 (+16.49%) Today
-$0.0158 (-3.35%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Acasti Pharma and other stocks, options, and ETFs commission-free!

About ACST

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil.

CEO
Janelle D'Alvise
Employees
—
Headquarters
Laval, Québec
Founded
2002

ACST Key Statistics

Market Cap
102.84M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
17.12M
High Today
$0.6198
Low Today
$0.4661
Open Price
$0.5663
Volume
96.52M
52 Week High
$1.22
52 Week Low
$0.171

ACST Earnings

-$0.26
-$0.05
$0.16
$0.37
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Jun 29, Pre-Market

You May Also Like

FEMB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure